766 related articles for article (PubMed ID: 30875980)
1. Modulation of Disordered Proteins with a Focus on Neurodegenerative Diseases and Other Pathologies.
Martinelli AHS; Lopes FC; John EBO; Carlini CR; Ligabue-Braun R
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30875980
[TBL] [Abstract][Full Text] [Related]
2. Insights into the Molecular Mechanisms of Alzheimer's and Parkinson's Diseases with Molecular Simulations: Understanding the Roles of Artificial and Pathological Missense Mutations in Intrinsically Disordered Proteins Related to Pathology.
Coskuner-Weber O; Uversky VN
Int J Mol Sci; 2018 Jan; 19(2):. PubMed ID: 29364151
[TBL] [Abstract][Full Text] [Related]
3. A Fragment-Based Method of Creating Small-Molecule Libraries to Target the Aggregation of Intrinsically Disordered Proteins.
Joshi P; Chia S; Habchi J; Knowles TP; Dobson CM; Vendruscolo M
ACS Comb Sci; 2016 Mar; 18(3):144-53. PubMed ID: 26923286
[TBL] [Abstract][Full Text] [Related]
4. Mixed pathologies in pancreatic β cells from subjects with neurodegenerative diseases and their interaction with prion protein.
Martinez-Valbuena I; Valenti-Azcarate R; Amat-Villegas I; Marcilla I; Marti-Andres G; Caballero MC; Riverol M; Tuñon MT; Fraser PE; Luquin MR
Acta Neuropathol Commun; 2021 Apr; 9(1):64. PubMed ID: 33832546
[TBL] [Abstract][Full Text] [Related]
5. Structures of the intrinsically disordered Aβ, tau and α-synuclein proteins in aqueous solution from computer simulations.
Nguyen PH; Derreumaux P
Biophys Chem; 2020 Sep; 264():106421. PubMed ID: 32623047
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of small-molecule binding to intrinsically disordered proteins.
Cuchillo R; Michel J
Biochem Soc Trans; 2012 Oct; 40(5):1004-8. PubMed ID: 22988855
[TBL] [Abstract][Full Text] [Related]
7. Fluspirilene Analogs Activate the 20S Proteasome and Overcome Proteasome Impairment by Intrinsically Disordered Protein Oligomers.
Fiolek TJ; Keel KL; Tepe JJ
ACS Chem Neurosci; 2021 Apr; 12(8):1438-1448. PubMed ID: 33788542
[TBL] [Abstract][Full Text] [Related]
8. Metal ions and intrinsically disordered proteins and peptides: from Cu/Zn amyloid-β to general principles.
Faller P; Hureau C; La Penna G
Acc Chem Res; 2014 Aug; 47(8):2252-9. PubMed ID: 24871565
[TBL] [Abstract][Full Text] [Related]
9. Formation of Heterotypic Amyloids: α-Synuclein in Co-Aggregation.
Bhasne K; Mukhopadhyay S
Proteomics; 2018 Nov; 18(21-22):e1800059. PubMed ID: 30216674
[TBL] [Abstract][Full Text] [Related]
10. Intrinsically disordered proteins in various hypotheses on the pathogenesis of Alzheimer's and Parkinson's diseases.
Coskuner O; Uversky VN
Prog Mol Biol Transl Sci; 2019; 166():145-223. PubMed ID: 31521231
[TBL] [Abstract][Full Text] [Related]
11. Common molecular pathogenesis of disease-related intrinsically disordered proteins revealed by NMR analysis.
Shigemitsu Y; Hiroaki H
J Biochem; 2018 Jan; 163(1):11-18. PubMed ID: 28992347
[TBL] [Abstract][Full Text] [Related]
12. Long-range correlated dynamics in intrinsically disordered proteins.
Parigi G; Rezaei-Ghaleh N; Giachetti A; Becker S; Fernandez C; Blackledge M; Griesinger C; Zweckstetter M; Luchinat C
J Am Chem Soc; 2014 Nov; 136(46):16201-9. PubMed ID: 25331250
[TBL] [Abstract][Full Text] [Related]
13. Intrinsically disordered proteins in the neurodegenerative processes: formation of tau protein paired helical filaments and their analysis.
Skrabana R; Sevcik J; Novak M
Cell Mol Neurobiol; 2006; 26(7-8):1085-97. PubMed ID: 16779670
[TBL] [Abstract][Full Text] [Related]
14. The Link between Type 2 Diabetes and Neurodegeneration: Roles for Amyloid-β, Amylin, and Tau Proteins.
Bharadwaj P; Wijesekara N; Liyanapathirana M; Newsholme P; Ittner L; Fraser P; Verdile G
J Alzheimers Dis; 2017; 59(2):421-432. PubMed ID: 28269785
[TBL] [Abstract][Full Text] [Related]
15. Current Challenges and Limitations in the Studies of Intrinsically Disordered Proteins in Neurodegenerative Diseases by Computer Simulations.
Akbayrak IY; Caglayan SI; Ozcan Z; Uversky VN; Coskuner-Weber O
Curr Alzheimer Res; 2020; 17(9):805-818. PubMed ID: 33167839
[TBL] [Abstract][Full Text] [Related]
16. Cross-Linking Mass Spectrometry Analysis of Metastable Compact Structures in Intrinsically Disordered Proteins.
Chen D; Joachimiak LA
Methods Mol Biol; 2023; 2551():189-201. PubMed ID: 36310204
[TBL] [Abstract][Full Text] [Related]
17. Lipid-Chaperone Hypothesis: A Common Molecular Mechanism of Membrane Disruption by Intrinsically Disordered Proteins.
Sciacca MF; Lolicato F; Tempra C; Scollo F; Sahoo BR; Watson MD; García-Viñuales S; Milardi D; Raudino A; Lee JC; Ramamoorthy A; La Rosa C
ACS Chem Neurosci; 2020 Dec; 11(24):4336-4350. PubMed ID: 33269918
[TBL] [Abstract][Full Text] [Related]
18. Application of native mass spectrometry in studying intrinsically disordered proteins: A special focus on neurodegenerative diseases.
Mitra G
Biochim Biophys Acta Proteins Proteom; 2019 Nov; 1867(11):140260. PubMed ID: 31382021
[TBL] [Abstract][Full Text] [Related]
19. Attempt to Untangle the Prion-Like Misfolding Mechanism for Neurodegenerative Diseases.
Sarnataro D
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30304819
[TBL] [Abstract][Full Text] [Related]
20. Biophysical studies of protein misfolding and aggregation in
Sinnige T; Stroobants K; Dobson CM; Vendruscolo M
Q Rev Biophys; 2020 Jun; 49():e22. PubMed ID: 32493529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
